Search details
1.
Sacituzumab govitecan: past, present and future of a new antibody-drug conjugate and future horizon.
Future Oncol
; 18(28): 3199-3215, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36069628
2.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34252375
3.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Lancet Oncol
; 19(1): 40-50, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29233559
4.
Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature.
Oncologist
; 23(8): 974-981, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29934412
5.
Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
Breast Cancer Res Treat
; 163(3): 495-506, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28315068
6.
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge.
Neurol Sci
; 36(1): 117-23, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25022241
7.
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.
Clin Cancer Res
; 29(17): 3384-3394, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37432976
8.
Evolution of synchronous female bilateral breast cancers and response to treatment.
Nat Med
; 29(3): 646-655, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36879128
9.
Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer.
Breast
; 62 Suppl 1: S70-S79, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34930649
10.
Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials.
Eur J Cancer
; 152: 193-203, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34116270
11.
Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(4): 565-572, 2021 Apr 01.
Article
in English
| MEDLINE | ID: mdl-33538790
12.
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2).
Eur J Cancer
; 156: 138-148, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34450552
13.
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer.
Clin Cancer Res
; 27(9): 2584-2591, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33593886
14.
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 145: 44-52, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33423006
15.
Optimal Systemic Treatment for Early Triple-Negative Breast Cancer.
Breast Care (Basel)
; 15(3): 217-226, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32774215
16.
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial.
JAMA Oncol
; 6(5): 744-748, 2020 05 01.
Article
in English
| MEDLINE | ID: mdl-32163106
17.
Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
Breast Cancer
; 26(6): 826-834, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31254201
18.
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial.
Clin Cancer Res
; 25(13): 3986-3995, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-30979740
19.
NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto.
J Clin Oncol
; 37(25): 2226-2234, 2019 09 01.
Article
in English
| MEDLINE | ID: mdl-31082269
20.
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor.
Clin Cancer Res
; 24(14): 3358-3365, 2018 07 15.
Article
in English
| MEDLINE | ID: mdl-29618617